Clinical Trials Browser

Radiotherapy, Image-Guided × Head & Neck × Clear all

NCT06568172 2026-03-19

Testing the Addition of an Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery to the Usual Surgery Alone for Treating Advanced Skin Cancer

Phase 3 Recruiting

420 enrolled

DermatologicHead & NeckSarcoma

Eyelid Squamous Cell Carcinoma

NCT07348887 2026-03-04

RTL-DART

Phase NA Recruiting

50 enrolled

Head & Neck

Squamous Cell Cancer of Head and Neck (SCCHN)

NCT06532279 2026-02-02

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

Phase 2 Recruiting

98 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Carcinoma, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms, Stomatitis

NCT06216171 2024-09-27

ProHEART

Phase NA Recruiting

30 enrolled

Head & Neck

Head and Neck Neoplasms

NCT06084845 2024-07-25

Testing the Addition of an Investigational Drug, Xevinapant, to Usual Radiation Therapy Plus Cisplatin/Carboplatin for Patients With Head and Neck Cancer

Phase 2 Withdrawn

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms

NCT01011842 2019-04-09

Real-Time kV Imaging vs. Real-Time 3D Patient Surface Tracking for Head & Neck Cancer

Phase NA Terminated

11 enrolled

Head & Neck

Head and Neck Neoplasms

NCT01853670 2015-03-30

IGRT

Phase NA Completed

6 enrolled

Head & Neck

Head and Neck Neoplasms